INTERNATIONAL PATENT: FRONTIER MEDICINES CORPORATION FILES APPLICATION FOR "COMBINATION OF A KRAS G12C INHIBITOR WITH AN IMMUNE CHECKPOINT INHIBITOR FOR THE TREATMENT OF CANCER"

GENEVA, Sept. 17 -- FRONTIER MEDICINES CORPORATION (151 Oyster Point Blvd., 2nd FloorSouth San Francisco, California 94080) filed a patent application (PCT/US2025/018217) for "COMBINATION OF A KRAS G12C INHIBITOR WITH AN IMMUNE CHECKPOINT INHIBITOR FOR THE TREATMENT OF CANCER" on Mar 03, 2025. With publication no. WO/2025/188668, the details related to the patent application was published on Sep 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WANG, Yan (c/o Frontier Medicines Corporation151 Oyster Point Blvd., 2nd FloorSouth San Francisco, California 94080), WEBSTER, Kevin (c/o Frontier ...